GMO Strategic Opportunities Allocation Fund;III
GBATX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- Boston MA 02110 New York NY United States of America 10017
- IPO Date
- May 31, 2005
- Website
- gothamfunds.com
- Similar Companies
- Business
- GMO Strategic Opportunities Allocation Fund Class III (GBATX) is an open-end mutual fund managed by Grantham, Mayo, Van Otterloo & Co. LLC (GMO) that seeks total return greater than its benchmark, the GMO Strategic Opportunities Allocation Index, a composite of 75% MSCI World Index and 25% Bloomberg U.S. Aggregate Index. Launched on May 31, 2005, and domiciled in the United States with headquarters at 53 State Street, Suite 3300, Boston, Massachusetts, the fund operates as a fund-of-funds, investing a significant portion of its assets in underlying GMO Trust series, including Equity Funds such as GMO International Equity Fund Class IV and GMO U.S. Opportunistic Value Fund Class VI; Fixed Income Funds; Implementation Funds like the Asset Allocation Bond Fund and Benchmark-Free Fund; and Alternative Funds including GMO Alternative Allocation Fund Class VI and GMO-Usonian Japan Value Creation Fund Class VI. It may also employ derivatives and short sales directly or through these underlying funds, with allocations across non-U.S. stocks (47.77%), U.S. bonds (43.68%), U.S. stocks (26.01%), non-U.S. bonds (4.96%), cash, and other assets, targeting sectors like financial services, technology, industrials, and consumer cyclical. The fund maintains a diversified global footprint, with regional exposures including the United States (34.64%), Japan (14.52%), Eurozone (13.33%), and United Kingdom (7.27%), serving institutional and high-net-worth investors through GMO's asset management platform that oversees approximately $78 billion in client assets across offices in Boston, San Francisco, London, Amsterdam, Singapore, Sydney, and Japan. Top holdings as of recent data represent 56.37% of the portfolio, led by GMO International Equity Fund Class IV (17.05%), GMO Alternative Allocation Fund Class VI (15.42%), GMO International Opportunistic Value Fund Class IV (8.65%), GMO U.S. Opportunistic Value Fund Class VI (8.07%), and GMO-Usonian Japan Value Creation Fund Class VI (7.18%). Managed primarily by Ben Inker since inception and John Thorndike since June 30, 2019, the fund features a net expense ratio of 0.84%, total net assets of approximately $63.93 million, 36 holdings, and 78% portfolio turnover. In recent developments, GMO Trust, encompassing GBATX, filed a Second Amended and Restated Application for Exemptive Relief with the U.S. Securities and Exchange Commission on June 26, 2025, signaling potential regulatory or structural adjustments to its operations. GMO has continued portfolio reallocations in response to market valuations, with ongoing reductions in holdings like Meta Platforms in 2024 quarters and dynamic shifts across underlying funds to reflect GMO's investment outlook. The firm launched the Dynamic Allocation ETF (GMOD) in 2025, extending its asset allocation expertise into ETF format, while maintaining focus on contrarian strategies amid market uncertainties, with no major acquisitions, partnerships, or reorganizations specific to GBATX reported in the last 1-2 years.